SFG
IBB icon

Summit Financial Group’s iShares Biotechnology ETF IBB Stock Holding History

Summit Financial Group’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		$1.39M Buy
10,149
+870
+9% +$119K 0.5% 59
2023
Q4 		$1.26M Hold
9,279
– – 0.48% 60
2023
Q3 		$1.13M Hold
9,279
– – 0.48% 61
2023
Q2 		$1.18M Hold
9,279
– – 0.46% 63
2023
Q1 		$1.2M Hold
9,279
– – 0.45% 65
2022
Q4 		$1.22M Buy
9,279
+700
+8% +$90.5K 0.48% 57
2022
Q3 		$1M Hold
8,579
– – 0.42% 71
2022
Q2 		$1.01M Hold
8,579
– – 0.39% 78
2022
Q1 		$1.12M Buy
8,579
+100
+1% +$13K 0.38% 76
2021
Q4 		$1.29M Sell
8,479
-6
-0.1% -$929 0.42% 68
2021
Q3 		$1.37M Hold
8,485
– – 0.5% 59
2021
Q2 		$1.39M Sell
8,485
-315
-4% -$48.5K 0.52% 56
2021
Q1 		$1.32M Buy
8,800
+55
+0.6% +$8.74K 0.55% 51
2020
Q4 		$1.32M Buy
8,745
+140
+2% +$20K 0.58% 50
2020
Q3 		$1.17M Buy
8,605
+35
+0.4% +$4.75K 0.58% 49
2020
Q2 		$1.17M Buy
8,570
+145
+2% +$18.5K 0.61% 44
2020
Q1 		$908K Hold
8,425
– – 0.54% 51
2019
Q4 		$1.01M Sell
8,425
-345
-4% -$38.5K 0.49% 52
2019
Q3 		$873K Sell
8,770
-1,875
-18% -$196K 0.44% 57
2019
Q2 		$1.16M Sell
10,645
-150
-1% -$16K 0.52% 52
2019
Q1 		$1.21M Hold
10,795
– – 0.94% 34
2018
Q4 		$1.04M Hold
10,795
– – 0.88% 37
2018
Q3 		$1.32M Hold
10,795
– – 0.98% 32
2018
Q2 		$1.19M Hold
10,795
– – 0.92% 34
2018
Q1 		$1.15M Sell
10,795
-50
-0.5% -$5.54K 0.9% 37
2017
Q4 		$1.16M Sell
10,845
-1,605
-13% -$172K 0.95% 36
2017
Q3 		$1.38M Sell
12,450
-30
-0.2% -$3.21K 1.15% 28
2017
Q2 		$1.29M Buy
+12,480
New +$1.23M 1.12% 27

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return

Summit Financial Group's IBB Position: Q1 2024 in Review

Summit Financial Group increased its iShares Biotechnology ETF (IBB) stake by 9.4% in Q1 2024, buying an estimated $119K and bringing the position to 10,149 shares worth $1.39M. The position accounts for 0.5% of the portfolio, ranked #59.

Summit Financial Group first reported a position in IBB in Q2 2017 and has held it in 28 quarters since. 899 funds tracked by Wall St. Rank hold IBB as of Q1 2024.

  • Summit Financial Group held 10,149 shares of iShares Biotechnology ETF worth $1.39M as of Q1 2024.
  • Summit Financial Group bought 870 iShares Biotechnology ETF shares in Q1 2024, an estimated $119K.
  • iShares Biotechnology ETF made up 0.5% of Summit Financial Group's portfolio in Q1 2024, its #59 holding.
  • Summit Financial Group first reported a position in iShares Biotechnology ETF in Q2 2017 and has held it in 28 quarters since.
  • 899 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2024.

Based on Summit Financial Group's 13F filing for Q1 2024, filed 5 Apr 2024.